Untargeted metabolomic analysis of coronary artery disease patients with diastolic dysfunction show disturbed oxidative pathway.
Tamkeen FatimaSatwat HashmiAyesha IqbalAmna Jabbar SiddiquiShahid A SamiNajeeb BasirSyeda Saira BokhariHasanat SharifSyed Ghulam MusharrafPublished in: Metabolomics : Official journal of the Metabolomic Society (2019)
Fifteen metabolites were found to be statistically different between cases and control. Variation in metabolites were identified and correlated with several clinically important echocardiography parameters i.e. LVDD grades, ejection fraction (EF) and E/e' values. The results suggested that metabolic products of fatty acid oxidation and glucose oxidation pathways such as oleic acid, stearic acid, palmitic acid, linoleic acid, galactose, pyruvic and lactic acids are predominantly up regulated in patients with coronary artery disease and severity of diastolic dysfunction appears to be linked to increase in fatty acid oxidation and inflammation. The metabolic fingerprints of these patients give us an insight into the pathophysiological mechanism of diastolic dysfunction in coronary artery disease patients although it did not identify validated novel markers.
Keyphrases
- cardiovascular events
- ejection fraction
- coronary artery disease
- aortic stenosis
- end stage renal disease
- fatty acid
- left ventricular
- oxidative stress
- percutaneous coronary intervention
- blood pressure
- chronic kidney disease
- computed tomography
- prognostic factors
- newly diagnosed
- ms ms
- heart failure
- mass spectrometry
- peritoneal dialysis
- type diabetes
- adipose tissue
- nitric oxide
- insulin resistance
- transcatheter aortic valve replacement
- high resolution
- patient reported outcomes
- metabolic syndrome
- blood glucose
- high resolution mass spectrometry
- visible light
- patient reported
- african american
- glycemic control